Fluid management
<p>The HysteroLux™ system enables uterine distention while monitoring a patient’s fluid deficit in real-time during hysteroscopic procedures.<sup>1</sup></p>
HysteroLux™ system benefits include:
| Item number | Description | Units per box |
|---|---|---|
| 72205000 | HysteroLux™ fluid management system control unit | 1 |
| 72205001 | HysteroLux™ fluid management system scale | 1 |
| 72205003 | HysteroLux country kit - UK | 1 |
| 72205004 | HysteroLux country kit - Western Europe | 1 |
| 72205005 | HysteroLux country kit - Mediterranean – EN, PT, ES, IT, EL, TR | 1 |
| 72205008 | HysteroLux country kit - Nordics – EN, SV, DA, FI, NO | 1 |
| 72205041 | Vacuum Regulator, CE marked | 1 |
| Item number | Description | Units per box |
|---|---|---|
| 72205015 | HysteroLux™ procedure kit (includes inflow tube set, outflow tube set, suction canister accessory kit) | 1 |
| 7209824 | Suction canister accessory kit | 1 |
| 72203257 | Single jumper procedure kit | 1 |
| 72205028 | HysteroLux™ inflow tube set | 10 |
| 7209823 | Hysteroscopic outflow tube set | 5 |
| 72205027 | HysteroLux™ vacuum tube set | 10 |
| 72200024 | 3000cc Hi-Flow™ canisters | 36 |
The smaller diameter TruClear™ 5C hysteroscope set enables a see-and-treat approach to intrauterine pathologies.
The TruClear™ Elite hysteroscopes enable a see-and-treat approach for intrauterine pathologies.
The TruClear™ dense tissue shaver provides tissue removal in hysteroscopic procedures and comes in both a plus and a mini size.
The TruClear™ set duo was developed for diagnostic and operative procedures in hysteroscopy. It includes a rigid hysteroscope to vizualise the uterine cavity.
The TruClear™ system offers a complete solution for diagnosing and treating intrauterine abnormalities that may be causing abnormal uterine bleeding.1
TruClear™ soft tissue shavers provide tissue removal in hysteroscopic procedures and comes in both a plus and mini size.1
Adverse effects for operative hysteroscopy include but are not limited to fluid overload due to intravasation and uterine perforation. Please refer to Instructions for Use (IFU) for complete contraindication and risk information. Residual risks to the patients may include but are not limited to exposure to body fluids, fetal distress, metastasis (cancer), peritonitis, abscess, and electric shock.
† Compared to our legacy hysteroscopic fluid management system.
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.